AIC
VIVO

Ameritas Investment Company’s Meridian Bioscience Inc VIVO Stock Holding History

Ameritas Investment Company’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-597
Closed -$15.7K – 2217
2021
Q1 		$15.7K Buy
+597
New +$14.2K ﹤0.01% 1375

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Investment Company's VIVO Position: Q2 2021 in Review

Ameritas Investment Company sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 597 shares — an estimated $15.7K sold.

Ameritas Investment Company first reported a position in VIVO in Q1 2021 and held it in 1 quarter. The position peaked at $15.7K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Ameritas Investment Company reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 597 Meridian Bioscience Inc shares in Q2 2021, an estimated $15.7K.
  • Ameritas Investment Company first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 1 quarter.
  • Ameritas Investment Company's Meridian Bioscience Inc position peaked at $15.7K in Q1 2021.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.